130 results
Page 4 of 7
6-K
EX-99.1
9i2v1ludb mi6h38v3
29 Sep 20
Current report (foreign)
7:00am
6-K
EX-1.1
l6a91p 2n8q3
11 Sep 20
Current report (foreign)
5:17pm
424B5
5y8qzrzjmwqrbxx4y
11 Sep 20
Prospectus supplement for primary offering
5:13pm
F-3
EX-4.7
kassk59i05p4sy3
28 Aug 20
Shelf registration (foreign)
4:02pm
F-3
mao7kxy
28 Aug 20
Shelf registration (foreign)
4:02pm
F-3
EX-4.6
dipy1jpl97bw03pdko
28 Aug 20
Shelf registration (foreign)
4:02pm
6-K
EX-99.2
g38ws54 i9ai2tn
7 Aug 20
Celyad Oncology Reports Half Year 2020 Financial Results and Second Quarter Business Highlights
7:35am
424B3
fuezwi8z 73qddo9
22 Jun 20
Prospectus supplement
10:52am
6-K
EX-99.1
ckg3nkbhi yz20ygu7
7 May 20
Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights
9:15am
6-K
EX-99.1
65ynhp2 ym544mmyg4ec
6 May 20
Celyad Appoints Seasoned Industry Executives to Board
11:44am
6-K
EX-99.1
zs7eyvb8dmfiz 3o70d5
25 Mar 20
Celyad Reports Full Year 2019 Financial Results and Provides Business Update
6:07am
6-K
EX-99.1
ejaymy qq
11 Mar 20
Celyad Appoints Stephen Rubino as Chief Business Officer
6:10am
6-K
EX-99.1
m6sk401a5eh7wvbox
2 Oct 19
Celyad to Present Update on mCRC Clinical
6:22am
6-K
EX-99.1
wd3d1 velg7fot
16 Sep 19
Celyad Announces Closing of $20 Million Global Offering
4:19pm
6-K
EX-1.1
f0ql23xp
12 Sep 19
Current report (foreign)
5:17pm